Trial Profile
Phase 1a safety and immunogenicity study of a universal flu vaccine
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 23 Apr 2012
Price :
$35
*
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions; Pharmacodynamics
- 10 Dec 2010 Results reported in a Dynavax media release.
- 10 Dec 2010 Full results to be reported at the World Health Organization 7th Meeting on Evaluation of Pandemic Influenza Prototype Vaccines in Clinical Trials, according to a Dynavax media release.
- 23 Sep 2010 Positive preliminary results reported in Dynavax media release; follow up data expected by the end of 2010.